PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis

2011-12-29
(Press-News.org) Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis (i.e., heart attack and stroke). However, a team of researchers led by Gary Owens, at the University of Virginia, Charlottesville, has now generated data in mice that raise potential concerns about this clinical trial — Owens and colleagues find that IL-1 limits the features of advanced atherosclerosis that are linked to the severe complications of the disease in humans.

### TITLE: Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

AUTHOR CONTACT:
Gary Owens
University of Virginia, Charlottesville, VA, USA
Phone: 434.924.2652; E-mail: gko@virginia.edu.


ELSE PRESS RELEASES FROM THIS DATE:

JCI online early table of contents: Dec. 27, 2011

2011-12-29
EDITOR'S PICK Another potential obstacle to developing an HIV vaccine A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]). A team of researchers led by Juliana McElrath, at the Fred Hutchinson Cancer Research ...

Tests for biomarker may help determine diagnosis of heart attack within hours

2011-12-29
CHICAGO – For patients admitted to an emergency department with chest pain, use of a contemporary or highly sensitive test for levels of troponin I (a protein in muscle tissue) may help rule-out a diagnosis of heart attack, while changes in the measured levels of this biomarker at 3 hours after admission may be useful to confirm a diagnosis of heart attack, according to a study in the December 28 issue of JAMA. One of the most common reasons patients seek care in an emergency department is for acute chest pain. "Early identification of individuals at high and intermediate ...

Perception of inappropriate care frequent among ICU workers

2011-12-29
CHICAGO – A survey of nurses and physicians in intensive care units (ICUs) in Europe and Israel indicated that the perception of inappropriate care, such as excess intensity of care for a patient, was common, and that these perceptions were associated with inadequate decision sharing, communication and job autonomy, according to a study in the December 28 issue of JAMA. "Clinicians perceive the care they provide as inappropriate when they feel that it clashes with their personal beliefs and/or professional knowledge. Intensive care unit workers who provide care perceived ...

Analysis does not support genetic test before use of anti-clotting drug

2011-12-29
CHICAGO – Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA. Clopidogrel is an antiplatelet drug used by approximately 40 million patients worldwide to treat or prevent ...

Possible Defenses To A DUI Charge

2011-12-29
You are sitting in your car, watching the red lights in your rearview mirror. The officer exits their vehicle and begins walking toward your car. The next thing you know, you have been charged with a DUI. What do you do now? You may think you have no chance, that even though you did not feel intoxicated or impaired, the blood alcohol content reading of the breathalyzer showed you were over the limit, and you are as good as convicted. Machines don't make mistakes, do they? Challenging A DWI Charge While it may seem an open and shut case, there may be multiple ...

Oxidative DNA damage repair

2011-12-29
Oxidative stress is the cause of many serious diseases such as cancer, Alzheimer's, arteriosclerosis and diabetes. It occurs when the body is exposed to excessive amounts of electrically charged, aggressive oxygen compounds. These are normally produced during breathing and other metabolic processes, but also in the case of ongoing stress, exposure to UV light or X-rays. If the oxidative stress is too high, it overwhelms the body's natural defences. The aggressive oxygen compounds destroy genetic material, resulting in what are referred to as harmful 8-oxo-guanine base mutations ...

Irikaitz archaeological site -- host to a 25,000-year-old pendant

2011-12-29
The recent discovery of a pendant at the Irikaitz archaeological site in Zestoa (in the Basque province of Gipuzkoa) has given rise to intense debate: it may be as old as 25,000 years, which would make it the oldest found to date at open-air excavations throughout the whole of the Iberian Peninsula. This stone is nine centimetres long and has a hole for hanging it from the neck although it would seem that, apart from being adornment, it was used to sharpen tools. The discovery has had great repercussion, but it is not by any means the only one uncovered here by the team ...

Whistleblowing Remedies in New Jersey

2011-12-29
Recent decisions by the New Jersey Supreme Court and the Appellate Division clarify the definition of "adverse employment action" that triggers New Jersey's "whistleblower law," known as the Conscientious Employee Protection Act (CEPA). Adverse Employment Action John Seddon had worked for Dupont 30 years when he filed a complaint with OSHA, the federal office for occupational safety and health. Seddon's complaint involved DuPont's practice of inspecting employee vehicles at the gate of the plant. Employees had to stand by the side of a busy ...

Targeted blocking of cell death prevents fatal condition septic shock

2011-12-29
Ghent, Belgium 27 December 2011 - Researchers of VIB and UGent have discovered a new approach to preventing septic shock, an often fatal extreme inflammatory reaction of the body. It is the most frequent cause of death at intensive care departments in hospitals. In sepsis, acute inflammation is attended by low blood pressure and blood clots, causing the organs to stop working. Only recently, the Brazilian football legend Socrates, died of the consequences of this condition. In a new study in the top journal Immunity, Peter Vandenabeele and colleagues of VIB-UGent described ...

Toasting the chemistry of champagne: New Year's Eve video from the American Chemical Society

Toasting the chemistry of champagne: New Years Eve video from the American Chemical Society
2011-12-29
WASHINGTON, Dec. 27, 2011 — Just in time for those New Year's Eve toasts, which might include a farewell to the International Year of Chemistry, the world's largest scientific society today posted online a video on the chemistry of champagne. The latest addition to the award-winning Bytesize Science series from the American Chemical Society (ACS) is available at www.BytesizeScience.com. It explains that champagne, unlike other wines, undergoes a second fermentation in the bottle to trap carbon dioxide gas, which dissolves into the wine and forms the fabled bubbles in ...

LAST 30 PRESS RELEASES:

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

[Press-News.org] Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis